Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-21-013316

Director sold 30,374 shares at an average $132.37 ($4,020,667)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2021-03-22 Sale −3,600 $129.36 $465,678 57,149 D
Bolzon Bradley J PhD Director 2021-03-22 Sale −3,413 $130.42 $445,112 53,736 D
Bolzon Bradley J PhD Director 2021-03-22 Sale −2,400 $131.14 $314,741 51,336 D
Bolzon Bradley J PhD Director 2021-03-22 Sale −6,090 $132.53 $807,092 45,246 D
Bolzon Bradley J PhD Director 2021-03-22 Sale −9,334 $133.28 $1,244,070 35,912 D
Bolzon Bradley J PhD Director 2021-03-22 Sale −5,237 $134.33 $703,495 30,675 D
Bolzon Bradley J PhD Director 2021-03-22 Sale −300 $134.93 $40,478 30,375 D
Open-market sales · 30,374 sh · avg $132.37 · $4,020,667
Loading xslF345X03/doc4.xml…